亞太地區生物銀行冷凍儲存設備市場：分析與預測（2024-2033）

預計亞太地區生物銀行保存設備市場規模在 2024 年將達到 2.969 億美元，到 2033 年將達到 6.479 億美元，在 2024-2033 年預測期內的複合年成長率為 9.06%。

為了支持基因組學、生物技術和藥物研究領域的市場發展，對血液、組織和DNA等生物樣本長期儲存的需求日益成長，這推動了亞太地區生物銀行低溫儲存設備市場的快速擴張。為了保持樣本的完整性和質量，亞太地區的生物銀行正在加大對低溫儲存系統、超低溫冷凍庫和高性能冷凍設備的投入。市場分為四大類：設備、耗材、軟體和服務。由於設備對生物銀行的運作至關重要，因此在市場中佔據主導地位。

自動化、溫度控制和節能冷卻技術的進步正在改善樣本管理和營運永續性。對臨床研究、再生醫學和精準醫學的日益重視正在推動相關研究。政府支持計劃、國家基因組計劃以及醫療保健投資的增加正在推動韓國、中國、日本和印度等國的市場成長。此外，日益嚴格的資料保護和生物安全法規正在推動安全合規的儲存基礎設備的普及。亞太地區正成為生物銀行創新的重要熱點地區，隨著研發機構、臨床試驗和生物技術中心的快速發展，該地區在樣本儲存、擴充性和技術改進方面樹立了新的標準。

市場介紹

由於中國、日本、印度、韓國和澳洲在基因組學、生物技術和精準醫療領域取得了顯著進展，亞太地區生物銀行低溫儲存設備市場正在快速擴張。該地區的生物銀行對於醫學研究、臨床試驗和個人化醫療至關重要，因為它能夠保存包括組織、血液、DNA和細胞株在內的各種生物資源。這導致對可靠且高效的低溫儲存系統（包括低溫儲存槽、超低溫冰箱和自動化樣本管理系統）的需求日益成長，以確保生物樣本的長期完整性。

政府支持的基因組學舉措、不斷成長的醫藥品研究開發費用以及不斷發展的學術和商業性生物銀行網路，都在推動市場成長。物聯網賦能的溫度監控、自動化和節能冷凍等技術進步，正在革新樣本保存流程，並提高可追溯性。此外，對生物標記發現和再生醫學的日益重視，也推動了相關設備在臨床和研究領域的應用。

然而，標準化儲存系統和不同的管理體制仍然是主要障礙。儘管如此，隨著基礎設施的穩定發展和公私合作日益密切，亞太地區正迅速成為全球的生物銀行創新中心，為生物醫學研究和精準醫療的進步做出貢獻。

市場區隔:

細分：按地區

• 亞太地區

亞太地區是生物銀行冷凍儲存設備市場成長最快的地區。生技和製藥產業的快速發展以及研發投入的不斷成長，正推動著中國、日本、印度和韓國等國家生物銀行的發展。這些國家正在擴大生物銀行基礎設施，以滿足基因組研究、診斷和精準醫療日益成長的需求。醫療保健支出的增加和臨床試驗的增加也刺激了該地區對先進冷凍儲存解決方案的需求。該地區對生物銀行能力的持續投資有望繼續推動對高效、擴充性冷凍儲存設備的需求。

亞太地區生物銀行冷凍保存設備市場趨勢、促進因素與挑戰：

市場趨勢

• 為支持基因組學和臨床研究，中國、日本、印度和韓國的生物銀行基礎設施正在迅速擴展。
• 自動化和物聯網冷資料儲存系統在即時溫度監控和高效樣品追蹤方面的應用日益廣泛。
• 精準醫療和個人化醫療的日益普及將推動對高品質、長期生物樣本儲存的需求。
• 加強人工智慧和雲端基礎平台在預測性維護、樣品庫存管理和數據分析方面的整合。
• 採用節能永續的冷凍技術，最大限度地降低營運成本和環境影響。
• 擴大公私合營和國際夥伴關係，以加強全部區域的生物銀行能力和標準化。
• 開發整合 LIMS（實驗室資訊管理系統）的數位生物銀行，以實現資料管理和增強合規性。

市場促進因素

• 政府大力資助和國家基因組計劃（例如中國的精準醫療計劃、印度的基因組計劃）以促進生物銀行和精準醫療的發展。
• 製藥和生物技術公司研發投入的增加將推動對先進冷凍保存解決方案的需求。
• 亞太地區醫療保健生態系統中臨床試驗和生物標記發現計畫不斷增加。
• 需要超低溫和冷凍保存的再生醫學和細胞療法研究的擴展。
• 生物醫學研究中越來越重視生物樣本的品質、可追溯性和法規遵循。
• 技術進步使得大規模生物銀行操作的自動化、擴充性和遠端監控成為可能。

市場挑戰

• 超低溫和低溫儲存系統的安裝和維護成本高。
• 由於亞太地區各國監管不一致，導致生物銀行標準分散化。
• 低溫運輸管理、生物銀行運作和數據分析方面缺乏熟練人員。
• 由於持續的超低溫運行和不斷上漲的電費，人們對能源消耗表示擔憂。
• 跨國研究合作中的資料隱私和生物樣本管治問題。
• 對進口設備和零件的依賴、不斷上漲的採購成本以及供應鏈的脆弱性。

本報告深入剖析了生物銀行低溫儲存設備的最新進展，包括溫度控制、自動化和雲端基礎監控系統等方面的創新。企業可以利用這些見解，發掘產品差異化機遇，開發新一代低溫儲存解決方案，並整合最尖端科技，以滿足生物銀行和個人化醫療日益成長的需求。

該報告詳細分析了各個地區和細分市場，使企業能夠瞄準生物銀行基礎設施需求快速成長的高成長地區。了解市場趨勢和區域動態將有助於企業調整行銷策略，並在高成長地區有效定位其產品，以滿足日益成長的先進冷凍保存解決方案的需求。

透過分析市場佔有率、主要參與企業和行業趨勢，公司可以評估競爭動態，識別市場領導，並製定策略以獲得競爭優勢，包括建立策略夥伴關係、進入新市場以及開發創新產品以滿足生物銀行和研究機構不斷變化的需求。

目錄

執行摘要

1. 亞太地區生物銀行低溫恆溫器市場概覽

• 市場概覽
• 法律規範
  • 日本
  • 中國
  • 巴西
• 專利分析
  • 專利申請趨勢（按國家/地區分類）
  • 專利申請趨勢（按年份）
• 生物銀行保存設備市場、供應鏈與價值鏈分析
• 市場動態概述
  • 市場促進因素
  • 市場限制
  • 市場機遇

第2章生物銀行冷凍保存設備市場（按地區分類），百萬美元，2022-2033年

• 區域摘要
• 亞太地區
  • 區域概覽
  • 市場成長促進因素
  • 成長抑制因素

第3章 市場競爭情勢

• 生物銀行冷凍保存設備市場：競爭格局
  • 策略發展，2021年1月至2024年12月
• 公司簡介
  • PHC Holding Corporation
  • Haier Biomedical
  • MGI Tech Co., Ltd.
  • Esco Micro Pte. Ltd.

第4章調查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Biobanking Cold Storage Equipment Market

The Asia-Pacific biobanking cold storage equipment market was valued at $296.9 million in 2024 and is anticipated to reach $647.9 million by 2033, witnessing a CAGR of 9.06% during the forecast period 2024-2033. The growing requirement for long-term preservation of biological samples, such as blood, tissues, and DNA, to support developments in genomics, biotechnology, and pharmaceutical research is driving the rapid expansion of the APAC Biobanking Cold Storage Equipment Market. To preserve sample integrity and quality, biobanks throughout Asia-Pacific are investing more in cryogenic storage systems, ultra-low temperature freezers, and sophisticated refrigeration units. The market is divided into four categories: equipment, consumables, software, and services. Because equipment is crucial to biobanking activities, it dominates the market.

Automation, temperature control, and energy-efficient refrigeration technological advancements are enhancing sample management and operational sustainability. Adoption is being accelerated by the area's increasing focus on clinical research, regenerative medicines, and precision medicine. The market is expanding because to supportive government initiatives, national genomics projects, and rising healthcare investments in nations like South Korea, China, Japan, and India. Additionally, the implementation of safe and compliant storage infrastructure is being encouraged by the growing regulatory focus on data protection and biosafety. The APAC area is becoming a significant hotspot for biobanking innovation, setting new standards in sample preservation, scalability, and technological improvement with the quick growth of R&D facilities, clinical trials, and biotechnology centers.

Market Introduction

The APAC Biobanking Cold Storage Equipment Market is expanding rapidly, owing to significant advances in genomics, biotechnology, and precision medicine in China, Japan, India, South Korea, and Australia. Because they preserve a variety of biological resources, such as tissues, blood, DNA, and cell lines, biobanks around the region are essential to medical research, clinical trials, and personalized healthcare initiatives. As a result, there is an increasing need for dependable and effective cold storage systems that guarantee long-term biosample integrity, such as cryogenic storage tanks, ultra-low temperature freezers, and automated sample management systems.

Government-backed genomics initiatives, rising pharmaceutical R&D expenditures, and a developing network of academic and commercial biobanks all contribute to the market's growth. IoT-enabled temperature monitoring, automation, and energy-efficient refrigeration are examples of technological advancements that are modernizing sample storage processes and improving traceability. Additionally, equipment use in clinical and research settings is increasing due to the rising emphasis on biomarker discovery and regenerative medicine.

Standardized storage systems and disparate regulatory regimes, however, continue to be major obstacles. Nevertheless, the APAC area is quickly becoming a global center for biobanking innovation, improving biomedical research and precision healthcare, thanks to robust infrastructure development and growing cooperation between the public and private sectors.

Market Segmentation:

Segmentation : by Region

• Asia-Pacific

The Asia-Pacific region is the fastest-growing market for biobanking cold storage equipment. Rapid advancements in biotechnology and pharmaceuticals, coupled with increasing research investments, drive the growth of biobanks in countries like China, Japan, India, and South Korea. These countries are expanding their biobanking infrastructure to support the growing demand for genomics research, diagnostics, and precision medicine. The rise in healthcare expenditures and the increasing number of clinical trials in the region also stimulate demand for advanced cold storage solutions. As the region continues to invest in biobanking capabilities, the demand for efficient and scalable cold storage equipment will continue to rise.

APAC Biobanking Cold Storage Equipment Market Trends, Drivers and Challenges:

Market Trends

• Rapid expansion of biobanking infrastructure across China, Japan, India, and South Korea to support genomic and clinical research.
• Growing adoption of automated and IoT-enabled cold storage systems for real-time temperature monitoring and efficient sample tracking.
• Increased focus on precision medicine and personalized healthcare, driving the need for high-quality, long-term biosample preservation.
• Rising integration of AI and cloud-based platforms for predictive maintenance, sample inventory management, and data analytics.
• Adoption of energy-efficient and sustainable refrigeration technologies to minimize operational costs and environmental impact.
• Growing public-private collaborations and international partnerships to strengthen biobanking capacity and standardization across the region.
• Development of digital biobanks integrating LIMS (Laboratory Information Management Systems) for enhanced data management and compliance.

Market Drivers

• Strong government funding and national genomics programs promoting biobanking and precision medicine (e.g., China's Precision Medicine Initiative, India's Genome Project).
• Increasing pharmaceutical and biotech R&D investments, boosting demand for advanced cold storage solutions.
• Rising number of clinical trials and biomarker discovery programs across APAC healthcare ecosystems.
• Expansion of regenerative medicine and cell therapy research, requiring ultra-low temperature and cryogenic preservation.
• Growing emphasis on biosample quality, traceability, and regulatory compliance in biomedical research.
• Technological advancements enabling automation, scalability, and remote monitoring for large-scale biobank operations.

Market Challenges

• High setup and maintenance costs of ultra-low temperature and cryogenic storage systems.
• Regulatory inconsistencies across APAC countries, leading to fragmented biobanking standards.
• Limited skilled workforce in cold chain management, biobank operations, and data analytics.
• Energy consumption concerns due to continuous ultra-low temperature operations and rising electricity costs.
• Data privacy and biosample governance issues in cross-border research collaborations.
• Dependence on imported equipment and components, increasing procurement costs and supply chain vulnerabilities.

How can this report add value to an organization?

Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.

Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions, capitalizing on the increasing need for advanced cold storage solutions.

Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.

Table of Contents

Executive Summary

Scope and Definition

1 Asia-Pacific Biobanking Cold Storage Equipment Market: Overview

• 1.1 Market Overview
• 1.2 Regulatory Framework
  • 1.2.1 Japan
    • 1.2.1.1 Regulatory Requirements for Biobanking Cold Storage Equipment Intended as Medical Devices
  • 1.2.2 China
    • 1.2.2.1 Regulatory Requirements for Biobanking Cold Storage Equipment Intended as Medical Devices
  • 1.2.3 Brazil
• 1.3 Patent Analysis
  • 1.3.1 Patent Filing Trend (by Country)
  • 1.3.2 Patent Filing Trend (by Year)
• 1.4 Biobanking Cold Storage Equipment Market, Supply/ Value Chain Analysis
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Growing Investments and Funding for Biobanks
    • 1.5.1.2 Increasing R&D Activities Using Biospecimens in Precision Medicine
    • 1.5.1.3 Technological Advancements and Automation in Biobanking
    • 1.5.1.4 Increasing Trend in Preservation of Cord Blood Stem Cells from Newborns
  • 1.5.2 Market Restraints
    • 1.5.2.1 Elevated Operational Costs for Biobanks
    • 1.5.2.2 High Legal and Ethical Challenges
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Emerging Economies to Provide Lucrative Opportunities

2 Biobanking Cold Storage Equipment Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
    • 2.2.3.1 China
    • 2.2.3.2 Japan
    • 2.2.3.3 Australia
    • 2.2.3.4 India
    • 2.2.3.5 Singapore
    • 2.2.3.6 Rest-of-Asia-Pacific

3 Markets - Competitive Landscape

• 3.1 Biobanking Cold Storage Equipment Market: Competitive Landscape
  • 3.1.1 Strategic Developments, January 2021- December 2024
• 3.2 Company Profiles
  • 3.2.1 PHC Holding Corporation
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products Offered
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Haier Biomedical
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 MGI Tech Co., Ltd.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Product Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View
  • 3.2.4 Esco Micro Pte. Ltd.
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products Offered
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers/End Users
    • 3.2.4.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Biobanking Cold Storage Equipment Market, $Million, 2024, 2028, and 2033
• Figure 2: Biobanking Cold Storage Equipment Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Number of Patents in Biobanking Cold Storage Equipment Market (by Country), January 2019-May 2024
• Figure 4: Number of Patent in Biobanking Cold Storage Equipment Market (by Year), January 2011-December 2024
• Figure 5: Supply/ Value Chain Analysis: Biobanking Cold Storage Equipment Market
• Figure 6: Legal and Ethical Challenges in Biobanking
• Figure 7: China Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 8: Japan Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 9: Australia Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 10: India Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 11: Singapore Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 12: Rest-of-Asia-Pacific Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 13: Strategic Developments, January 2021- December 2024
• Figure 14: Data Triangulation
• Figure 15: Top-Down and Bottom-Up Approach
• Figure 16: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Asia-Pacific Biobanking Cold Storage Equipment Market Opportunities
• Table 3: Impact Analysis of Market Navigating Factors, 2022-2033
• Table 4: Operational and Direct Labor Costs
• Table 5: Biobanking Cold Storage Equipment Market (by Region), $Million, 2022-2033
• Table 6: Asia-Pacific Biobanking Cold Storage Equipment Market (by Country), $Million, 2022-2033